Recombinant adenoviral vector with encoded TLR3 ligand for protection against VEE

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/09 → 8/31/12

Funding

  • Vaxart, Inc ( Award #5R43AI07725402): $106,905.00